BioSpace News Archive

Policy

Innomane Inc. Announces Health Canada Approval and Canadian Launch of Diaronex®, an Over-The-Counter Herbal Remedy to Help Relieve Diarrhea

Innomane Inc. announces today the Health Canada approval and Canadian launch of Diaronex®, a natural and herbal remedy made from the herb Holarrhena, which is recognized by World Health Organization to help relieve diarrhea.

September 13, 2018
·
3 min read
Pharm Country

Immunotherapy Market Value Grows as the Treatments Gains Widespread Importance

According to a report published by Progressive Markets, the cancer immunotherapy market was valued at USD 57.2 Billion in 2017 and is expected to reach USD 166.7 Billion by 2025 while growing at a compound annual growth (CAGR) of 14.42%.

September 13, 2018
·
11 min read
Pharm Country

U.S. Medical Cannabis Market Set to Expand as Legalization Rapidly Spreads

According to a report published by Hexa Research, the U.S. medical cannabis market size was valued at USD 5.44 Billion in 2016 and is anticipated to reach USD 19.48 Billion by 2024.

September 13, 2018
·
12 min read
Business

Biolog-id Branches out to the United States with a New Operational Center in Atlanta

Biolog-id today announced the establishment of its U.S. operational center in Atlanta.

September 13, 2018
·
3 min read
Biotech Beach

Legendary Actor Ed Asner, Celebrity Chef Art Smith and Emmy-Winning Television Executive and Producer Elaine Frontain Bryant to be Honored at A Night Of Dreams Benefiting The Ed Asner Family Center

The Ed Asner Family Center presents its first annual A NIGHT OF DREAMS Gala, honoring Emmy®-winning actor Ed Asner

September 13, 2018
·
6 min read
Drug Development

AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress

Across all doses, a significantly greater proportion of patients who remained on upadacitinib showed continuous improvements in skin lesions and pruritus (itch) at week 32 compared to patients re-randomized to placebo[1]

September 13, 2018
·
12 min read
Deals

Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock

Sensus Healthcare, Inc. announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share.

September 13, 2018
·
6 min read
Policy

Information Update - Health Canada advises of a second impurity linked to recalled valsartan drugs

Health Canada is advising Canadians that a second impurity, called N-nitrosodiethylamine (NDEA) has been found in valsartan manufactured by Zhejiang Huahai Pharmaceuticals in China.

September 13, 2018
·
2 min read
Biotech Beach

Best Self Medical Arts Offers GAINSWave® in California

Best Self Medical Arts is pleased to announce they now offer GAINSWave!

September 13, 2018
·
1 min read
Job Trends

Simply Radiant Offers GAINSWave® in Nevada

Simply Radiant is pleased to announce they now offer GAINSWave!

September 13, 2018
·
2 min read